Alberto Fernández

ORCID: 0000-0003-3153-3929
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Esophageal and GI Pathology
  • Esophageal Cancer Research and Treatment
  • Autoimmune and Inflammatory Disorders
  • Diagnosis and treatment of tuberculosis
  • Cancer, Lipids, and Metabolism
  • Gastric Cancer Management and Outcomes
  • Gastrointestinal motility and disorders
  • Tuberculosis Research and Epidemiology
  • Celiac Disease Research and Management
  • Animal Genetics and Reproduction
  • Mycobacterium research and diagnosis
  • Peroxisome Proliferator-Activated Receptors
  • Genomics and Phylogenetic Studies
  • Lipoproteins and Cardiovascular Health
  • Complementary and Alternative Medicine Studies
  • Whipple's Disease and Interleukins
  • Forensic and Genetic Research
  • Infant Health and Development
  • Gastrointestinal disorders and treatments
  • Molecular Biology Techniques and Applications
  • Dermatology and Skin Diseases
  • Congenital gastrointestinal and neural anomalies

Povisa Hospital
2012-2025

Clínica Rementería
2020

The Epi-IBD cohort is a prospective population-based inception of unselected patients with inflammatory bowel disease from 29 European centres covering background population almost 10 million people. aim this study was to assess the 5-year outcome and course Crohn's (CD).Patients were followed up prospectively time diagnosis, including collection their clinical data, demographics, activity, medical therapy, surgery, cancers deaths. Associations between outcomes multiple covariates analysed...

10.1136/gutjnl-2017-315568 article EN Gut 2018-01-23
Johan Burisch Hillel Vardi Doron Schwartz Michael Friger Gediminas Kiudelis and 85 more Juozas Kupčinskas Mathurin Fuméry Corinne Gower‐Rousseau Péter L. Lakatos Péter L. Lakatos R. D’Incà Alessandro Sartini Daniela Valpiani M. Giannotta Naila Arebi Dana Duricova Martin Bortlík Stefania Chetcuti Zammit Pierre Ellul Natalia Pedersen Jens Kjeldsen Jóngerð Midjord Kári Rubek Nielsen Karina Winther Andersen Vibeke Andersen Konstantinos H. Katsanos Dimitrios Christodoulou Viktor Domislović Željko Krznarić Shaji Sebastian Pia Oksanen Pekka Collin Luísa Leite Barros Fernando Magro Riina Salupere Hendrika Adriana Linda Kievit Adrian Goldiș Ioannis Kaimakliotis Jens F Dahlerup Carl Eriksson Jonas Halfvarson Alberto Fernández Vicent Hernandez Svetlana Turcan Elena Belousova Ebbe Langholz Pia Munkholm Selwyn Odes Nikša Turk Silvija Čuković‐Čavka Anastasia Nicolaou Milan Lukáš Olga Shonová Birgitte Blichfeldt Dorte Marker Katrine Carlsen Petra Weimers Clays Aalykke Karen Kudsk Ida Vind Niels Thorsgaard Alexandros Skamnelos Dimitrios Politis Zsuzsanna Végh Peterne Demenyi Szabina Nemethne Kramli Giualia Dal Piaz A. Santini Giulia Girardin Limas Kupčinskas Laimas Jonaitis Irena Valantienė Romanas Zykus Rūta Kučinskienė Daniela Lazăr Inna Nikulina Luisa de Castro Juan-Ramon Pineda Santos Pereira J Martínez-Cadilla L Sanromán Montserrat Figueira D. Martínez Ares J I Rodríguez-Prada Amalia Carmona Carlos González-Portela Ulla-Britt Widen Sally Myers Katherine M. Ashton Emma Whitehead

10.1016/s2468-1253(20)30012-1 article EN ˜The œLancet. Gastroenterology & hepatology 2020-02-13

The aim of the present study was to validate IBD (inflammatory bowel diseases) incidence reported in 2010 ECCO-EpiCom (European Crohn's and Colitis Organization-Epidemiological Committee) inception cohort by including a second independent from participating centers 2011 an Australian center investigate whether there is difference between Eastern Western European countries Australia.Fourteen 5 9 one Australia participated cohort. Patients' data regarding disease type, socio-demographic...

10.1016/j.crohns.2014.06.004 article EN Journal of Crohn s and Colitis 2014-07-03

Health-related quality of life (HRQoL) is impaired in patients with Inflammatory Bowel Disease (IBD). The aim was prospectively to assess and validate the pattern HRQoL an unselected, population-based inception cohort IBD from Eastern Western Europe. EpiCom consists 1560 31 European centres covering a background population approximately 10.1 million. Patients answered disease specific Short Questionnaire (SIBDQ) generic Form 12 (SF-12) questionnaire at diagnosis after one year follow-up. In...

10.1016/j.crohns.2014.01.028 article EN Journal of Crohn s and Colitis 2014-02-21

No direct comparison of health care cost in patients with inflammatory bowel disease across the European continent exists. The aim this study was to assess costs investigations and treatment for diagnostics during first year after diagnosis Europe.The EpiCom cohort is a prospective population-based inception unselected from 31 Western Eastern centers. Patients were followed every third month diagnosis, clinical data regarding collected. Costs calculated euros (€) using Danish Health...

10.1097/mib.0000000000000250 article EN Inflammatory Bowel Diseases 2014-11-28

Abstract Background The Epi-IBD cohort is a prospective European population-based of 1,508 patients diagnosed in 2010 and 2011 with inflammatory bowel disease (IBD) according to Copenhagen criteria centres across 17 countries. study aims describe treatment strategies, course prognosis IBD unclassified (IBDU) Europe. Methods Patients IBDU were defined as not fulfilling the diagnostic Crohn’s (CD) or ulcerative colitis (UC), but still required related monitoring. They followed prospectively...

10.1093/ecco-jcc/jjae190.1432 article EN Journal of Crohn s and Colitis 2025-01-01

Introduction: coeliac disease (CD) is a chronic of the small intestine, which caused by gluten intolerance, producing malabsorption nutrients and vitamins.Clinical manifestations CD in adults are highly variable, including intestinal extra-intestinal symptoms.The may also occur individuals who asymptomatic.Objective: our objective to describe incidence clinical adults.Material methods: retrospective study was carried out patients diagnosed between January 1990 December 2008.Diagnosis based...

10.4321/s1130-01082010000800002 article EN Revista Española de Enfermedades Digestivas 2010-08-01
Johan Burisch Zsuzsanna Végh K. Katsanos Dimitrios Christodoulou Daniela Lazăr and 95 more Adrian Goldis Colm OʼMorain Alberto Fernández Santos Pereira Sally Myers Shaji Sebastian Natalia Pedersen Jóngerð Olse Kári Rubek Nielsen Doron Schwartz Selwyn Odes Sven Almér Jonas Halfvarson Nikša Turk S. Čuković-Čavka Inna Nikulina E. А. Belousova Dana Ďuricová Martin Bortlík Olga Shonová Riina Salupere Louisa Barros Fernando Magro Laimas Virginijus Jonaitis Limas Kupčinskas Svetlana Turcan Ioannis Kaimakliotis Karin Ladefoged Karen Kudsk Vibeke Andersen Ida Vind Niels Thorsgaard Pia Oksanen Pekka Collin Giulia Dal Piaz A. Santini Ola Niewiadomski Sally Bell Bjørn Moum Naila Arebi Jens Kjeldsen Katrine Carlsen Ebbe Langholz Péter L. Lakatos Pia Munkholm Lars Ulrik Gerdes Jens Frederik Dahlerup Ola Niewiadomski Sally Bell Nikša Turk Silvija Čuković‐Čavka Ioannis Kaimakliotis Anastasia Nicolaou Dana Ďuricová Milan Lukáš Martin Bortlík Olga Shonová Johan Burisch Pia Munkholm Ebbe Langholz Birgitte Blichfeldt Dorte Marker Katrine Carlsen Petra Weimers Natalia Pedersen Jens Kjeldsen Clays Aalykke Jens Frederik Dahlerup Karen Kudsk Vibeke Andersen Ida Vind Niels Thorsgaard Riina Salupere Jóngerð Olsen Kári Rubek Nielsen Pia Oksanen Pekka Collin K. Katsanos Dimitrios Christodoulou Alexandros Skamnelos Dimitrios Politis Karin Ladefoged Péter L. Lakatos Zsuzsanna Végh Péter L. Lakatos Peterne Demenyi Szabina Nemethne Kramli Colm OʼMorain Giualia Dal Piaz A. Santini Giulia Girardin R. D’Incà Doron Schwartz Selwyn Odes Limas Kupčinskas

Anaemia is an important complication of inflammatory bowel disease [IBD]. The aim this study was to determine the prevalence anaemia and practice screening during first year following diagnosis, in a European prospective population-based inception cohort.Newly diagnosed IBD patients were included followed prospectively for 1 29 one Australian centre. Clinical data including demographics, medical therapy, surgery blood samples collected. defined according World Health Organization criteria.A...

10.1093/ecco-jcc/jjx077 article EN Journal of Crohn s and Colitis 2017-05-25

The EpiCom-study investigates a possible East-West-gradient in Europe the incidence of IBD and association with environmental factors. A secured web-based database is used to facilitate centralize data registration.To construct validate inception cohort available both English Russian language.The EpiCom has been constructed collaboration all 34 participating centers. was translated into using forward translation, patient questionnaires were by simplified forward-backward translation. Data...

10.1016/j.crohns.2011.02.016 article EN other-oa Journal of Crohn s and Colitis 2011-06-03

Background: Epidemiological studies have shown a greater prevalence of irritable bowel syndrome (IBS) and inflammatory disease (IBD) among first-degree relatives patients diagnosed these diseases. However, it is not known whether with IBD IBS than the general population.

10.1016/j.crohns.2011.01.008 article EN Journal of Crohn s and Colitis 2011-04-18

Objetive: Self-expandable plastic stents (SEPS) are increasingly being used for treatment of postoperative esophageal leak.This complication occurs in 4-27% patients after radical gastrectomy, and has a high mortality rate up to 60%.The aim this study is evaluate the efficacy SEPS (Polyflex ® ) post-operative eshopago-jejuno anastomosis leak gastrectomy gastric cancer.Material methods: During one year period who underwent our hospital cancer developed anastomotic were prospectively included...

10.4321/s1130-01082010001200005 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2010-12-01

The use of fully covered metal stents (FCMS) for the treatment benign conditions is increasing. aim our study was to assess efficacy FCMS in management post-operative leaks after gastric or esophageal surgery.During a three year period (2011-2013), patients who underwent surgery related with cancer and developed postoperative anastomotic leak treated were prospectively included.Fourteen included (11 men, 3 women), median age 65 years. Placement at least one stent achieved 13 (93% cases),...

10.17235/reed.2015.3765/2015 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2015-01-01

to validate the incidence of inflammatory bowel disease (IBD) reported in Vigo 2010 within Epi-IBD study, which was highest so far Spain.an epidemiological, prospective, population-based inception cohort study. All incident cases IBD living area at diagnosis from January 1 December 31, 2011 were included.one hundred patients diagnosed (62 % men; median age, 43.27 years): 49 with ulcerative colitis (UC), 34 Crohn's (CD), and 17 unclassified (IBDU). The (per 100,000 inhabitants/year) 17.56...

10.17235/reed.2021.8003/2021 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2021-01-01

Abstract Background The Epi-IBD cohort is a prospective European population-based of 1,390 patients diagnosed in 2010 and 2011 with inflammatory bowel disease (IBD) according to Copenhagen criteria centres from Eastern Western countries. study aims at describing differences incidence, treatment strategies, course prognosis Crohn’s (CD) across Europe. Methods CD were followed prospectively the time diagnosis until December 31st, 2020, death, emigration or loss follow-up. Clinical data on...

10.1093/ecco-jcc/jjac190.0018 article EN Journal of Crohn s and Colitis 2023-01-30

Abstract Background The Epi-IBD cohort is a prospective European population-based of 1,390 patients diagnosed in 2010 and 2011 with inflammatory bowel disease (IBD) according to Copenhagen criteria centres from Eastern Western countries. study aims at describing differences incidence, treatment strategies, course prognosis ulcerative colitis (UC) Europe. Methods UC were followed prospectively the time diagnosis until December 31st, 2020, death, emigration or loss follow-up. Clinical data on...

10.1093/ecco-jcc/jjac190.1005 article EN Journal of Crohn s and Colitis 2023-01-30
Coming Soon ...